| Income Statement |
| Total Revenue | 508.00M |
|
| Revenues (USD) | 508.00M |
| Cost of Revenue | 273.00M |
| Gross Profit | 235.00M |
| Operating Expenses | 265.00M |
| Research and Development Expense | 207.00M |
| Selling, General and Administrative Expense | 58.00M |
| Operating Income | -30.00M |
| Income Tax Expense | 4.00M |
| Net Income | -21.00M |
| Net Income Common Stock | -21.00M |
| Net Income Common Stock (USD) | -21.00M |
| Consolidated Income | -21.00M |
| Earnings per Basic Share | -0.03 |
| Earnings per Basic Share (USD) | -0.03 |
| Earnings per Diluted Share | -0.03 |
| Earning Before Interest & Taxes (EBIT) | -17.00M |
| Earning Before Interest & Taxes (USD) | -17.00M |
| Weighted Average Shares | 818.00M |
| Weighted Average Shares Diluted | 818.00M |
| Balance Sheet |
| Cash and Equivalents | 1.31B |
| Cash and Equivalents (USD) | 1.31B |
| Investments | 132.00M |
| Investments Current | 132.00M |
| Trade and Non-Trade Receivables | 208.00M |
| Current Assets | 2.08B |
| Property, Plant & Equipment Net | 472.00M |
| Total Assets | 8.84B |
| Current Liabilities | 452.00M |
| Total Liabilities | 628.00M |
| Accumulated Retained Earnings (Deficit) | -7.29B |
| Accumulated Other Comprehensive Income | 12.00M |
| Shareholders Equity | 8.21B |
| Shareholders Equity (USD) | 8.21B |
| Assets Non-Current | 6.76B |
| Goodwill and Intangible Assets | 5.98B |
| Inventory | 310.00M |
| Liabilities Non-Current | 176.00M |
| Trade and Non-Trade Payables | 253.00M |
| Tax Liabilities | 5.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 136.00M |
| Net Cash Flow from Financing | -24.00M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 98.00M |
| Capital Expenditure | -21.00M |
| Issuance (Purchase) of Equity Shares | -24.00M |
| Net Cash Flow from Investing | -20.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | 1000.00K |
| Net Cash Flow from Operations | 135.00M |
| Effect of Exchange Rate Changes on Cash | 7.00M |
| Share Based Compensation | 88.00M |